ESCMID 2025

ESCMID 2025
April 11-15, 2025
Vienna,Austria

Congress of the European Society of
 Clinical Microbiology and Infectious Diseases.

Explore more information for Gilead COVID-19 therapies
Material Type
Filter by Keyword(s)

Filter results with keywords such as:

  • Name of author(s)
  • Disease state
  • Indication
  • Trial phase
  • Trial name
  • Trial date

Note: Multiple keywords can be applied at the same time.

    Results (4)

    Early Versus Late Versus No Remdesivir Initiation in Patients With Immunocompromising Conditions Hospitalised With COVID-19

    • Author(s): Berry, M
    • remdesivir
    • COVID-19
    • Poster

    Routinely Captured Measurements of Vital Signs Within Long-Term Care Facilities Indicate Substantial and Sustained Physiological Health Impacts Associated With COVID-19

    • Author(s): Dickinson, H
    • other
    • COVID-19
    • Poster

    Viral Resistance Analyses From the Obeldesivir BIRCH Study in High-Risk Nonhospitalised Patients With COVID-19

    • Author(s): Hedskog, C
    • obeldesivir
    • COVID-19
    • Poster

    Viral Resistance Analyses From the Obeldesivir OAKTREE Study in Low-Risk Nonhospitalised Patients With COVID-19

    • Author(s): Rodriguez, L
    • remdesivir
    • COVID-19
    • Poster